title: [Asthenic disorders and cognitive dysfunction in patients with tension headache].
abstract: The article is devoted to the study of cognitive dysfunction in patients suffering from tension headaches. Patients had attention and memory dysfunction, higher levels of anxiety, asthenia and subclinical symptoms of depression. The high efficacy of cerebrolysin in the restoration of cognitive dysfunction confirmed by the data of clinical, psychological and neuropsychological studies was shown.
authors.forename: L S
authors.initials: LS
authors.lastname: Chutko
authors.forename: S Iu
authors.initials: SIu
authors.lastname: Surushkina
authors.forename: A V
authors.initials: AV
authors.lastname: Rozhkova
authors.forename: E A
authors.initials: EA
authors.lastname: Iakovenko
authors.forename: Iu L
authors.initials: IuL
authors.lastname: Bykova
authors.forename: I S
authors.initials: IS
authors.lastname: Nikishina
mesh_terms: D000328:Adult; D000596:Amino Acids / Q000627:therapeutic use*; D001247:Asthenia / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D001288:Attention / Q000502:physiology; D001921:Brain / Q000503:physiopathology; D003071:Cognition / Q000502:physiology; D003072:Cognition Disorders / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D018696:Neuroprotective Agents / Q000627:therapeutic use; D009483:Neuropsychological Tests; D011379:Prognosis; D018781:Tension-Type Headache / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology
chemical_list: D000596:Amino Acids; D018696:Neuroprotective Agents; C006952:cerebrolysin